C135H136N40O11S — CID 165079909
2-(2-imidazol-1-ylethoxy)-5-pyridin-2-ylpyrazine;2-[(1-methylimidazol-2-yl)methoxy]-5-pyridin-2-ylpyrazine;2-[(3-methylimidazol-4-yl)methoxy]-5-pyridin-2-ylpyrazine;2-(2-piperidin-1-ylethoxy)-5-pyridin-2-ylpyrazine;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]benzimidazole;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]piperidin-2-one;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]pyrrolidin-2-one;2-[(5-pyridin-2-ylpyrazin-2-yl)oxymethyl]-1,3-thiazole;2-pyridin-2-yl-5-(2-pyrrolidin-1-ylethoxy)pyrazine (PubChem CID 165079909) has the molecular formula C135H136N40O11S and a molecular weight of 2526.91 g/mol. Its IUPAC name is 2-(2-imidazol-1-ylethoxy)-5-pyridin-2-ylpyrazine;2-[(1-methylimidazol-2-yl)methoxy]-5-pyridin-2-ylpyrazine;2-[(3-methylimidazol-4-yl)methoxy]-5-pyridin-2-ylpyrazine;2-(2-piperidin-1-ylethoxy)-5-pyridin-2-ylpyrazine;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]benzimidazole;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]piperidin-2-one;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]pyrrolidin-2-one;2-[(5-pyridin-2-ylpyrazin-2-yl)oxymethyl]-1,3-thiazole;2-pyridin-2-yl-5-(2-pyrrolidin-1-ylethoxy)pyrazine.
| Compound Name | 2-(2-imidazol-1-ylethoxy)-5-pyridin-2-ylpyrazine;2-[(1-methylimidazol-2-yl)methoxy]-5-pyridin-2-ylpyrazine;2-[(3-methylimidazol-4-yl)methoxy]-5-pyridin-2-ylpyrazine;2-(2-piperidin-1-ylethoxy)-5-pyridin-2-ylpyrazine;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]benzimidazole;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]piperidin-2-one;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]pyrrolidin-2-one;2-[(5-pyridin-2-ylpyrazin-2-yl)oxymethyl]-1,3-thiazole;2-pyridin-2-yl-5-(2-pyrrolidin-1-ylethoxy)pyrazine |
|---|---|
| PubChem CID | 165079909 |
| Molecular Formula | C135H136N40O11S |
| Molecular Weight | 2526.91 g/mol |
| Exact Mass | 2525.10 |
| IUPAC Name | 2-(2-imidazol-1-ylethoxy)-5-pyridin-2-ylpyrazine;2-[(1-methylimidazol-2-yl)methoxy]-5-pyridin-2-ylpyrazine;2-[(3-methylimidazol-4-yl)methoxy]-5-pyridin-2-ylpyrazine;2-(2-piperidin-1-ylethoxy)-5-pyridin-2-ylpyrazine;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]benzimidazole;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]piperidin-2-one;1-[2-(5-pyridin-2-ylpyrazin-2-yl)oxyethyl]pyrrolidin-2-one;2-[(5-pyridin-2-ylpyrazin-2-yl)oxymethyl]-1,3-thiazole;2-pyridin-2-yl-5-(2-pyrrolidin-1-ylethoxy)pyrazine |
| SMILES | Cn1ccnc1COc1cnc(-c2ccccn2)cn1.Cn1cncc1COc1cnc(-c2ccccn2)cn1.O=C1CCCCN1CCOc1cnc(-c2ccccn2)cn1.O=C1CCCN1CCOc1cnc(-c2ccccn2)cn1.c1ccc(-c2cnc(OCCN3CCCC3)cn2)nc1.c1ccc(-c2cnc(OCCN3CCCCC3)cn2)nc1.c1ccc(-c2cnc(OCCn3ccnc3)cn2)nc1.c1ccc(-c2cnc(OCCn3cnc4ccccc43)cn2)nc1.c1ccc(-c2cnc(OCc3nccs3)cn2)nc1 |
| InChI | InChI=1S/C18H15N5O.C16H18N4O2.C16H20N4O.C15H16N4O2.C15H18N4O.3C14H13N5O.C13H10N4OS/c1-2-7-17-15(6-1)22-13-23(17)9-10-24-18-12-20-16(11-21-18)14-5-3-4-8-19-14;21-16-6-2-4-8-20(16)9-10-22-15-12-18-14(11-19-15)13-5-1-3-7-17-13;1-4-8-20(9-5-1)10-11-21-16-13-18-15(12-19-16)14-6-2-3-7-17-14;20-15-5-3-7-19(15)8-9-21-14-11-17-13(10-18-14)12-4-1-2-6-16-12;1-2-6-16-13(5-1)14-11-18-15(12-17-14)20-10-9-19-7-3-4-8-19;1-19-10-15-6-11(19)9-20-14-8-17-13(7-18-14)12-4-2-3-5-16-12;1-19-7-6-16-13(19)10-20-14-9-17-12(8-18-14)11-4-2-3-5-15-11;1-2-4-16-12(3-1)13-9-18-14(10-17-13)20-8-7-19-6-5-15-11-19;1-2-4-14-10(3-1)11-7-17-12(8-16-11)18-9-13-15-5-6-19-13/h1-8,11-13H,9-10H2;1,3,5,7,11-12H,2,4,6,8-10H2;2-3,6-7,12-13H,1,4-5,8-11H2;1-2,4,6,10-11H,3,5,7-9H2;1-2,5-6,11-12H,3-4,7-10H2;2-8,10H,9H2,1H3;2-9H,10H2,1H3;1-6,9-11H,7-8H2;1-8H,9H2 |
| InChIKey | UYGZPMACWOURIM-UHFFFAOYSA-N |
| XLogP | 18.94 |
| TPSA | 562.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 187 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2526.91 |
| LogP ≤ 5 | 18.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 50 |